Marketed plasma-derived VWF/FVIII concentrate

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
288	自己免疫性後天性凝固因子欠乏症	1

288. 自己免疫性後天性凝固因子欠乏症

臨床試験数 : 206 / 薬物数 : 231 - (DrugBank : 28) / 標的遺伝子数 : 10 - 標的パスウェイ数 : 21

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00816660 (ClinicalTrials.gov)	December 1, 2008	2/1/2009	Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Fa ...	Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex (rVWF:rFVIII): A Phase 1 Study E ...	Von Willebrand Disease	Biological: Recombinant von Willebrand factor : recombinant FVIII (rVWF:rFVIII);Biological: Marketed ...	Baxalta now part of Shire	NULL	Completed	18 Years	60 Years	All	32	Phase 1	United States;Austria;Canada;Germany;Italy;United Kingdom

First Previous1Next Last